Category

Merkel Cell Carcinoma Disease Treatment Market Size, Share, Opportunities, And Trends By Treatment (Immunotherapy, Surgical Excision, Radiation Therapy, Others), By Disease Stage (Local (Skin Only), Nodal (includes Lymph Nodes), Metastatic (spreads Elsewhere In The Body)), And Geography - Forecasts From 2019 To 2024

Report Code:  KSI061612273 | Pages:  101

The merkel cell carcinoma disease treatment market was valued at US$2.914 billion in 2018 and is anticipated to grow at a CAGR of 3.13% to reach a market size of US$3.506 billion by 2024. The presence of the Merkel cells can be found in the touch-sensitive area of the epidermis, which is also known as the outermost layer of the skin. Merkel cell carcinoma is considered to be an aggressive form of skin cancer which metastasizes very fast to other areas of the body. There are several drugs are in the pipeline for the development of the effective disease treatment. However, the exact cause of the disease is unknown, but excessive sunlight exposure and a weakened immune system may aggravate the risk of cancer. Rising disease incidence, rising healthcare expenditure, and growing research and development investments are driving the growth of the Merkel cell carcinoma disease treatment market in the forecast period. Europe and North America are expected to hold a significant market share due to the growing incidences of this disease in the United States, France, Germany, and Sweden among other regions. Additionally, China and Australia from the APAC region also have growing incidences of Merkel cell carcinoma where the market may thrive owing to the need for disease treatment in these regions.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the merkel cell carcinoma disease treatment value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the merkel cell carcinoma disease treatment market.

Major industry players profiled as part of the report are Merck KGaA, Darmstadt, Germany, Pfizer Inc., Millennium Pharmaceuticals Inc., APCure SAS, and Bristol-Myers Squibb Company among others.

Segmentation

The merkel cell carcinoma disease treatment market has been analyzed through following segments:

By Treatment

  • Immunotherapy

  • Surgical Excision

  • Radiation Therapy

  • Others

By Disease Stage

  • Local (Skin only)

  • Nodal (includes lymph nodes)

  • Metastatic (spreads elsewhere in the body)

By Geography

  • North America

    • USA

    • Canada

    • Mexico

    • Others

  • South America

    • Brazil

    • Argentina

    • Others

  • Europe

    • Germany

    • France

    • United Kingdom

    • Spain

    • Others

  • Middle East and Africa

    • Saudi Arabia

    • Israel

    • Others

  • Asia Pacific

    • China

    • Japan

    • South Korea

    • India

    • Others

OUR CLIENTS